Phyto-Med operates in Healthcare, Nutraceuticals, Pharmaceuticals, Natural Products, functioning as Manufacturer and Supplier and Retailer, based in Canada.
Phyto-Med is active in Healthcare, Nutraceuticals, Pharmaceuticals, Natural Products, with 3 identified product associations including Combinaison Barbe De Maïs-Lx, Pr-Lx, and 3 ingredient links such as Silicon dioxide, Arctostaphylos Uva-Ursi (English), operating from Canada.
Phyto-Med is linked to 3 ingredients: Silicon dioxide, Arctostaphylos Uva-Ursi (English), Bifidobacterium Longum. INCI names include silica, Arctostaphylos Uva Ursi Leaf Extract. CAS references: 7631-86-9, 497-76-7.
Phyto-Med has 3 product records: Combinaison Barbe De Maïs-Lx, Pr-Lx, Pr-Lx, under brands: Phyto-Med Inc., within the Healthcare ecosystem.
Phyto-Med has 5 people records, including Phytotherapeute, Phtomed, across Entry levels.
This profile combines organization, product, ingredient, and narrative signals into a higher-fidelity company record.
CAS: 7631-86-9 · INCI: silica
CAS: 497-76-7 · INCI: Arctostaphylos Uva Ursi Leaf Extract
CAS: 12650-88-3 · INCI: Lactobacillus Ferment
Brand: Phyto-Med Inc. · Industry: Healthcare
Brand: Phyto-Med Inc. · Industry: Healthcare
Brand: Phyto-Med Inc. · Industry: Healthcare
Phyto-Med has 5 people records, including Phytotherapeute, Phtomed, across Entry levels.
Phyto-Med is related to companies such as SOLACTIS Group, Helixor Heilmittel GmbH, Botanica Pharmaceutics, identified through shared industry signals, ingredient overlap, and product ecosystem alignment.
Data-backed questions about Phyto-Med in Healthcare, Nutraceuticals, Pharmaceuticals, Natural Products, Canada.
© Copyright 2026 Dietary Business Intelligence LLC. All Rights Reserved.
